A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies-Reference-Cited by-同舟云学术

A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies

Published:2023-02 Issue:2 Volume:26 Page:185-192
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Palmer Stephen,Borget Isabelle,Friede Tim,Husereau Don,Karnon Jonathan,Kearns Ben,Medin Emma,Peterse Elisabeth F.P.,Klijn Sven L.,Verburg-Baltussen Elisabeth J.M.,Fenwick Elisabeth,Borrill John

Funder

Bristol-Myers Squibb

National Institute for Health and Care Research

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference39 articles.

1. Estimating lifetime benefits associated with immuno-oncology therapies: challenges and approaches for overall survival extrapolations;Ouwens;Pharmacoeconomics,2019

2. Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection;Bullement;BMC Med Res Methodol,2020

3. Extrapolation of survival curves using standard parametric models and flexible parametric spline models: comparisons in large registry cohorts with advanced cancer;Gray;Med Decis Making,2021

4. What did time tell us? A comparison and retrospective validation of different survival extrapolation methods for immuno-oncologic therapy in advanced or metastatic renal cell carcinoma;Klijn;Pharmacoeconomics,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know;PharmacoEconomics;2024-07-05

2. Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study;Value in Health;2024-07

3. Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling;PharmacoEconomics;2024-03-18

4. Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study;ClinicoEconomics and Outcomes Research;2024-02

5. Assessing the Performance of Alternative Methods for Estimating Long-Term Survival Benefit of Immuno-oncology Therapies;Value in Health;2024-02